Skip to main content
Clinical Trials/NCT00005650
NCT00005650CompletedNot Applicable

Genetic Study of Patients With Primary Ciliary Dyskinesia

National Center for Research Resources (NCRR)1 site in 1 country180 target enrollmentStarted: February 2000Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
180
Locations
1

Study Overview

Brief Summary

OBJECTIVES:

I. Characterize the clinical presentation of patients with primary ciliary dyskinesia.

II. Identify the genetic mutations associated with this disease.

Detailed Description

PROTOCOL OUTLINE:

Participants undergo a scrape biopsy acquisition of nasal cells for ciliary studies, a chest radiograph, sinus radiographs, lung function tests, sputum cultures, nitric oxide measurement, and an ear, nose and throat evaluation to screen for primary ciliary dyskinesia (PCD). Blood collection and/or a buccal scrape is also performed for genetic studies.

Genetic studies include molecular linkage analyses, genetic mapping, and gene mutation identification based on large deletions. Microsatellite markers are used to identify polymorphism.

Genetic counseling is provided to all participants.

Study Design

Study Type
Observational
Observational Model
Natural History

Eligibility Criteria

Ages
0 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor
National Center for Research Resources (NCRR)
Sponsor Class
Nih

Study Sites (1)

Loading locations...

Similar Trials

Genetic Study of Patients With Primary... | Clinical Trial